Peptide Companion
Back to catalog
Peptide Companion
single
Anti-Aging
Vial: 20 mg

Prostamax (20 mg Vial)

Prostamax is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Pro / KEDP) derived from prostate tissue peptide complex research. Short peptides of this class have been studied for their ability to modulate gene expression through epigenetic interactions with chromatin and histones. This educational protocol presents a once‑daily intramuscular approach using a practical dilution for clear insulin‑syringe measurements.

Detailed protocol below.

Dosing Schedule
Phase / WeekDaily Dose (mcg / mg)Units (per injection) (mL)
Weeks 1–2500 mcg (0.5 mg)5 units (0.05 mL)
Weeks 3–4750 mcg (0.75 mg)7.5 units (0.075 mL)
Weeks 5–81,000 mcg (1 mg)10 units (0.10 mL)
Weeks 9–12 (optional extension)1,000 mcg (1 mg)10 units (0.10 mL)
Supplies Needed
  • •Peptide Vials (Prostamax, 20 mg each):
  • •Insulin Syringes (U‑100, 30‑ or 50‑unit recommended for precision):
  • •Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
References

  • Modern Research in Inflammation (2013)

    Experimental study of Prostamax efficiency in chronic aseptic prostatitis therapy and complications

    View source

  • Modern Research in Inflammation (2014)

    Experimental study of tetrapeptide Lysyl-Glutamyl-Aspartyl-Proline in benign prostatic hyperplasia model

    View source

  • Bulletin of Experimental Biology and Medicine (2004)

    Effects of short peptides on lymphocyte chromatin in senile subjects (KEDP and chromatin decondensation)

    View source

  • Stem Cell Reviews and Reports (2020)

    Peptide regulation of cell differentiation: epigenetic mechanisms of short bioregulatory peptides

    View source

  • CDC (Subcut Injection PDF)

    Technique diagram and site guidance for subcutaneous injections

    View source

  • CDC

    Vaccine administration: During vaccination (aspiration guidance, aseptic technique)

    View source

  • NIBSC (MHRA)

    Peptide handling, dissolution, and storage best practices

    View source

  • NCBI Bookshelf

    Best practices for injection (asepsis, preparation, and administration)

    View source

  • CDC

    General best practices for immunization: injection technique and safety

    View source

  • Subcutaneous Drug Injection Review (PMC)

    Pharmacologic considerations of the subcutaneous route

    View source

Educational content adapted from peptidedosages.com. Not medical advice.